Gilda Rechici, Cesare Maino, Davide Ippolito, Rocco Corso
{"title":"COVID-19 对乳腺放射科管理的影响:自 2020 年以来我们学到了什么?系统回顾","authors":"Gilda Rechici, Cesare Maino, Davide Ippolito, Rocco Corso","doi":"10.1016/j.hsr.2024.100162","DOIUrl":null,"url":null,"abstract":"<div><p>During the last years, the COVID-19 pandemic determined different clinical and radiological scenarios, sometimes difficult to manage, in particular in breast units. On these bases, we tried to understand what we have learned and how to improve the management of breast cancer screening and breast cancer patients.</p><p>We included a total number of 16 studies. Most published papers about managing breast units during the spread of COVID-19 were editorial, followed by original articles and reviews. Even if the COVID spread followed a bimodal distribution, most papers were published during the first wave, without significant improvement in 2021 and 2022, and were published in journals belonging to general speciality, followed by surgical and radiological journals.</p><p>One of the most common topics reported in the final included studies is prioritizing patients in the clinical setting according to individual characteristics (first of all, age), risk factors, and time since the last imaging examination. For biopsies, prioritization has been suggested according to the risk of malignant lesions. In the screening setting, this was suspended in most reported studies, also for BRCA+ patients, and then resumed with different modalities according to different centres. Moreover, some proposed the establishment of mobile units for screening or the decentralization of more screening mammograms to smaller clinics or hospital admittance for screening patients via telemedicine.</p><p>The majority of analyzed papers underlined that all patients, before admittance into the diagnostic rooms, should be screened for suspicious symptoms directly on-site or by asking by phone. In the case of patients with a high suspicion of COVID-19 infection, some papers proposed to delay all breast imaging studies and others to use dedicated departments or areas of the cancer center. In this setting, telemedicine for radiologists has also been suggested. Moreover, other suggestions should be considered: reducing patients' time in the hospital, increasing the distance between patients in the waiting room, and creating additional waiting areas.</p></div>","PeriodicalId":73214,"journal":{"name":"Health sciences review (Oxford, England)","volume":"11 ","pages":"Article 100162"},"PeriodicalIF":0.0000,"publicationDate":"2024-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772632024000151/pdfft?md5=d589af713f27a6b800ff02435a28baf8&pid=1-s2.0-S2772632024000151-main.pdf","citationCount":"0","resultStr":"{\"title\":\"The impact of COVID-19 in the management of breast radiology units: What we have learned since 2020? A systematic review\",\"authors\":\"Gilda Rechici, Cesare Maino, Davide Ippolito, Rocco Corso\",\"doi\":\"10.1016/j.hsr.2024.100162\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>During the last years, the COVID-19 pandemic determined different clinical and radiological scenarios, sometimes difficult to manage, in particular in breast units. On these bases, we tried to understand what we have learned and how to improve the management of breast cancer screening and breast cancer patients.</p><p>We included a total number of 16 studies. Most published papers about managing breast units during the spread of COVID-19 were editorial, followed by original articles and reviews. Even if the COVID spread followed a bimodal distribution, most papers were published during the first wave, without significant improvement in 2021 and 2022, and were published in journals belonging to general speciality, followed by surgical and radiological journals.</p><p>One of the most common topics reported in the final included studies is prioritizing patients in the clinical setting according to individual characteristics (first of all, age), risk factors, and time since the last imaging examination. For biopsies, prioritization has been suggested according to the risk of malignant lesions. In the screening setting, this was suspended in most reported studies, also for BRCA+ patients, and then resumed with different modalities according to different centres. Moreover, some proposed the establishment of mobile units for screening or the decentralization of more screening mammograms to smaller clinics or hospital admittance for screening patients via telemedicine.</p><p>The majority of analyzed papers underlined that all patients, before admittance into the diagnostic rooms, should be screened for suspicious symptoms directly on-site or by asking by phone. In the case of patients with a high suspicion of COVID-19 infection, some papers proposed to delay all breast imaging studies and others to use dedicated departments or areas of the cancer center. In this setting, telemedicine for radiologists has also been suggested. Moreover, other suggestions should be considered: reducing patients' time in the hospital, increasing the distance between patients in the waiting room, and creating additional waiting areas.</p></div>\",\"PeriodicalId\":73214,\"journal\":{\"name\":\"Health sciences review (Oxford, England)\",\"volume\":\"11 \",\"pages\":\"Article 100162\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2772632024000151/pdfft?md5=d589af713f27a6b800ff02435a28baf8&pid=1-s2.0-S2772632024000151-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Health sciences review (Oxford, England)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2772632024000151\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health sciences review (Oxford, England)","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772632024000151","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
在过去的几年中,COVID-19 的流行决定了不同的临床和放射学情况,有时很难管理,尤其是在乳腺科。在此基础上,我们试图了解我们学到了什么,以及如何改进对乳腺癌筛查和乳腺癌患者的管理。在 COVID-19 传播期间,发表的有关乳腺科管理的论文大多是社论,其次是原创文章和综述。即使COVID的传播呈双峰分布,但大多数论文都发表在第一波,2021年和2022年没有明显改善,而且都发表在属于普通专业的期刊上,其次是外科和放射学期刊。在最后纳入的研究中,最常见的主题之一是在临床环境中根据个体特征(首先是年龄)、风险因素和上次成像检查后的时间来确定患者的优先次序。对于活组织检查,有人建议根据恶性病变的风险确定优先顺序。在筛查环境中,大多数报告的研究都暂停了这一工作,BRCA+患者也是如此,然后根据不同的中心采用不同的方式恢复了这一工作。此外,一些研究还建议设立流动筛查单位,或将更多的乳腺 X 线造影筛查工作下放到较小的诊所,或通过远程医疗将患者送入医院进行筛查。大多数分析论文都强调,所有患者在进入诊断室之前,应直接在现场或通过电话询问的方式筛查可疑症状。对于高度怀疑感染 COVID-19 的患者,一些论文建议推迟所有乳腺成像检查,另一些则建议使用癌症中心的专用部门或区域。在这种情况下,也有人建议放射科医生使用远程医疗。此外,还应该考虑其他建议:缩短患者在医院的时间、增加候诊室中患者之间的距离以及增设候诊区。
The impact of COVID-19 in the management of breast radiology units: What we have learned since 2020? A systematic review
During the last years, the COVID-19 pandemic determined different clinical and radiological scenarios, sometimes difficult to manage, in particular in breast units. On these bases, we tried to understand what we have learned and how to improve the management of breast cancer screening and breast cancer patients.
We included a total number of 16 studies. Most published papers about managing breast units during the spread of COVID-19 were editorial, followed by original articles and reviews. Even if the COVID spread followed a bimodal distribution, most papers were published during the first wave, without significant improvement in 2021 and 2022, and were published in journals belonging to general speciality, followed by surgical and radiological journals.
One of the most common topics reported in the final included studies is prioritizing patients in the clinical setting according to individual characteristics (first of all, age), risk factors, and time since the last imaging examination. For biopsies, prioritization has been suggested according to the risk of malignant lesions. In the screening setting, this was suspended in most reported studies, also for BRCA+ patients, and then resumed with different modalities according to different centres. Moreover, some proposed the establishment of mobile units for screening or the decentralization of more screening mammograms to smaller clinics or hospital admittance for screening patients via telemedicine.
The majority of analyzed papers underlined that all patients, before admittance into the diagnostic rooms, should be screened for suspicious symptoms directly on-site or by asking by phone. In the case of patients with a high suspicion of COVID-19 infection, some papers proposed to delay all breast imaging studies and others to use dedicated departments or areas of the cancer center. In this setting, telemedicine for radiologists has also been suggested. Moreover, other suggestions should be considered: reducing patients' time in the hospital, increasing the distance between patients in the waiting room, and creating additional waiting areas.